Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 155B 135B 124B 116B 218B 14,872B 222B 1,482B 574B 7,169B 583B 570B 24,926B P/E Ratio 2026 *
22.4x
P/E Ratio 2027 * 19.2x
Enterprise Value 167B 145B 134B 125B 234B 15,995B 239B 1,594B 617B 7,710B 627B 614B 26,808B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3x
Free-Float
86.73%
Yield 2026 *
2.85%
Yield 2027 * 3.04%
1 day+0.21%
1 week-1.65%
Current month+4.30%
1 month+8.15%
3 months-19.02%
6 months-27.58%
Current year-28.74%
1 week 88.69
Extreme 88.69
92.73
1 month 82.69
Extreme 82.69
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
04-27Other

Head of Human Resources

5,314 0.0003%
04-23Free

Director

2,286 0.0001%
04-23Other

Director

131,451 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-1.65%-34.00%-11.95% 155B
-0.25%-2.35%-9.15%-5.07% 103B
+1.05%+5.06%-0.93%+58.37% 54.72B
-0.23%-6.71%+50.66%+49.87% 53.65B
-1.07%-2.29%-15.39%-41.71% 40.72B
-0.92%+5.07% - - 30.9B
-0.13%+2.74%-10.13%-41.23% 28.85B
-1.31%+2.96%+45.84%-8.59% 23.38B
-1.93%-0.66%-14.31%+2.17% 21.22B
-0.85%-2.81%-14.31%-0.77% 20.31B
Average -0.54%+2.23%-0.19%+0.12% 53.21B
Weighted average by Cap. -0.20%+2.16%-7.98%+0.86%

Financials

2026 *2027 *
Net sales 50.29B 43.64B 40.23B 37.69B 70.43B 4,815B 71.89B 480B 186B 2,321B 189B 185B 8,071B 54.8B 47.56B 43.84B 41.08B 76.75B 5,247B 78.35B 523B 202B 2,529B 206B 201B 8,795B
Net income 7.02B 6.09B 5.61B 5.26B 9.83B 672B 10.03B 66.97B 25.93B 324B 26.35B 25.78B 1,126B 8.17B 7.09B 6.53B 6.12B 11.44B 782B 11.68B 77.94B 30.17B 377B 30.66B 30B 1,311B
Net Debt 11.73B 10.18B 9.38B 8.79B 16.42B 1,123B 16.76B 112B 43.32B 541B 44.02B 43.07B 1,882B 8.88B 7.71B 7.11B 6.66B 12.44B 851B 12.7B 84.76B 32.82B 410B 33.35B 32.63B 1,426B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-06-11 89.33 $ +0.18% 3,527,922
26-06-10 89.17 $ -2.28% 11,853,108
26-06-09 91.25 $ +0.83% 14,109,595
26-06-08 90.50 $ -0.63% 13,308,687
26-06-05 91.07 $ +0.32% 11,933,748
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
89.17USD
Average target price
117.29USD
Spread / Average Target
+31.54%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!